Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $1.81 Million Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS decreased its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,777 shares of the company’s stock after selling 1,818 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Bath & Body Works were worth $1,814,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Fifth Third Wealth Advisors LLC lifted its holdings in shares of Bath & Body Works by 4.9% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock valued at $271,000 after buying an additional 324 shares during the last quarter. SRS Capital Advisors Inc. lifted its stake in Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after acquiring an additional 329 shares during the last quarter. TD Private Client Wealth LLC grew its position in Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after acquiring an additional 331 shares in the last quarter. UMB Bank n.a. increased its stake in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after purchasing an additional 335 shares during the last quarter. Finally, Lindbrook Capital LLC lifted its stake in shares of Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Trading Down 0.7 %

Shares of NYSE:BBWI opened at $32.19 on Wednesday. The firm has a market capitalization of $6.90 billion, a PE ratio of 7.85, a PEG ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a 1-year low of $26.21 and a 1-year high of $52.99. The business’s 50 day moving average is $35.52 and its 200-day moving average is $34.03.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. On average, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.49%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works’s payout ratio is 21.98%.

Bath & Body Works declared that its board has approved a stock buyback program on Thursday, February 27th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to reacquire up to 6.4% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

BBWI has been the topic of several analyst reports. Barclays lowered their target price on shares of Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating on the stock in a research report on Monday, March 3rd. Raymond James reissued an “outperform” rating and issued a $46.00 price objective (up from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Telsey Advisory Group reissued an “outperform” rating and issued a $43.00 price target on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Robert W. Baird upped their price objective on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a report on Friday, February 28th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Moderate Buy” and a consensus target price of $45.06.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.